Ensaios clínicos de Enxaqueca em Utah
7 estudos para Enxaqueca estão buscando participantes em locais em Utah.
Cidades em Utah
Texto oficial do estudo (Inglês)
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- JBR Clinical Research, Salt Lake City
- Wasatch Clinical Research , LLC(Administrative Location), Salt Lake City
RecrutandoFase 3
Idades de 6 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- JBR Clinical Research, Salt Lake City
- Wasatch Clinical Research , LLC(Administrative Location), Salt Lake City
RecrutandoFase 3
Idades de 6 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT04743141A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Pantheon Clinical Research /ID# 270259, Bountiful
- Alpine Research Organization - Clinton /ID# 276527, Clinton
- Highland Clinical Research /ID# 270281, Salt Lake City
RecrutandoFase 3
Idades de 12 a 17 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Advanced Research Institute Ogden, Ogden
RecrutandoFase 4
Idades de 18 a 70 · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Pantheon Clinical Research /ID# 250703, Bountiful
- Highland Clinical Research /ID# 239362, Salt Lake City
RecrutandoFase 3
Idades de 6 a 17 · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05125302Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Highland Research, Salt Lake City
RecrutandoFase 2
Idades de 18 a 65 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07646613A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Pantheon Clinical Research, Bountiful
- J. Lewis Research, Inc. / Foothill Family Clinic Draper, Draper
- Advanced Research Institute, Ogden
- e mais 3
RecrutandoFase 3
Idades de 18 a 75 · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07645924Fonte: ClinicalTrials.gov, dados obtidos em 2 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.